Rhabdomyosarcoma development in mice lacking Trp53 and Fos: Tumor suppression by the Fos protooncogene

Cancer Cell

Volumn 4, Issue 6, 2003, Pages 477-482

  Fleischmann, Alexander ^a,c   Jochum, Wolfram ^b   Eferl, Robert ^a   Witowsky, James ^a   Wagner, Erwin F ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN FOS;

AGE DISTRIBUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; FACE CANCER; GENE INTERACTION; GENE TRP; MOUSE; MYOBLAST; NONHUMAN; ORBIT CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0347628826     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00280-0     Document Type: Article

References (37)

1. Anderson M.J., Shelton G.D., Cavenee W.K., Arden K.C. Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3. Proc. Natl. Acad. Sci. USA. 98:2001;1589-1594.
2. Ayyanathan K., Fredericks W.J., Berking C., Herlyn M., Balakrishnan C., Gunther E., Rauscher F.J. 3rd. Hormone-dependent tumor regression in vivo by an inducible transcriptional repressor directed at the PAX3-FKHR oncogene. Cancer Res. 60:2000;5803-5814.
3. Barr F.G., Galili N., Holick J., Biegel J.A., Rovera G., Emanuel B.S. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3:1993;113-117.
4. Bergers G., Graninger P., Braselmann S., Wrighton C., Busslinger M. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15:1995;3748-3758.
5. Bernasconi M., Remppis A., Fredericks W.J., Rauscher F.J. 3rd, Schafer B.W. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc. Natl. Acad. Sci. USA. 93:1996;13164-13169.
6. Davis R.J., D'Cruz C.M., Lovell M.A., Biegel J.A., Barr F.G. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res. 54:1994;2869-2872.
7. Diller L., Kassel J., Nelson C.E., Gryka M.A., Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker S.J., Vogelstein B.et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10:1990;5772-5781.
8. Epstein J.A., Shapiro D.N., Cheng J., Lam P.Y., Maas R.L. Pax3 modulates expression of the c-Met receptor during limb muscle development. Proc. Natl. Acad. Sci. USA. 93:1996;4213-4218.
9. Finkel M.P., Biskis B.O., Jinkins P.B. Virus induction of osteosarcomas in mice. Science. 151:1966;698-701.
10. Galili N., Davis R.J., Fredericks W.J., Mukhopadhyay S., Rauscher F.J. 3rd, Emanuel B.S., Rovera G., Barr F.G. Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 5:1993;230-235.
11. Ginsberg J.P., Davis R.J., Bennicelli J.L., Nauta L.E., Barr F.G. Up-regulation of MET but not neural cell adhesion molecule expression by the PAX3-FKHR fusion protein in alveolar rhabdomyosarcoma. Cancer Res. 58:1998;3542-3546.
12. Grigoriadis A.E., Schellander K., Wang Z.Q., Wagner E.F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122:1993;685-701.
13. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., Wagner E.F. c-Fos. a key regulator of osteoclast-macrophage lineage determination and bone remodeling Science. 266:1994;443-448.
14. Hafezi F., Steinbach J.P., Marti A., Munz K., Wang Z.Q., Wagner E.F., Aguzzi A., Reme C.E. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat. Med. 3:1997;346-349.
15. Hahn H., Wojnowski L., Zimmer A.M., Hall J., Miller G., Zimmer A. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat. Med. 4:1998;619-622.
16. Harvey M., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A., Donehower L.A. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet. 5:1993;225-229.
17. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4:1994;1-7.
18. Jochum W., Passegue E., Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene. 20:2001;2401-2412.
19. Johnson R.S., Spiegelman B.M., Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell. 71:1992;577-586.
20. Khan J., Simon R., Bittner M., Chen Y., Leighton S.B., Pohida T., Smith P.D., Jiang Y., Gooden G.C., Trent J.M., Meltzer P.S. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58:1998;5009-5013.
21. Khan J., Bittner M.L., Saal L.H., Teichmann U., Azorsa D.O., Gooden G.C., Pavan W.J., Trent J.M., Meltzer P.S. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA. 96:1999;13264-13269.
22. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
23. Margue C.M., Bernasconi M., Barr F.G., Schafer B.W. Transcriptional modulation of the anti-apoptotic protein BCL-XL by the paired box transcription factors PAX3 and PAX3/FKHR. Oncogene. 19:2000;2921-2929.
24. Merlino G., Helman L.J. Rhabdomyosarcoma-working out the pathways. Oncogene. 18:1999;5340-5348.
25. Nanni P., Nicolett G., De Giovanni C., Croci S., Astolfi A., Landuzzi L., Di Carlo E., Iezzi M., Musiani P., Lollini P.L. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Cancer Res. 63:2003;2728-2732.
26. Orlandini M., Marconcini L., Ferruzzi R., Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. Proc. Natl. Acad. Sci. USA. 93:1996;11675-11680.
27. Pedraza-Alva G., Zingg J.M., Jost J.P. AP-1 binds to a putative cAMP response element of the MyoD1 promoter and negatively modulates MyoD1 expression in dividing myoblasts. J. Biol. Chem. 269:1994;6978-6985.
28. Saez E., Rutberg S.E., Mueller E., Oppenheim H., Smoluk J., Yuspa S.H., Spiegelman B.M. c-fos is required for malignant progression of skin tumors. Cell. 82:1995;721-732.
29. Schreiber M., Baumann B., Cotten M., Angel P., Wagner E.F. Fos is an essential component of the mammalian UV response. EMBO J. 14:1995;5338-5349.
30. Seale P., Sabourin L.A., Girgis-Gabardo A., Mansouri A., Gruss P., Rudnicki M.A. Pax7 is required for the specification of myogenic satellite cells. Cell. 102:2000;777-786.
31. Sharp R., Recio J.A., Jhappan C., Otsuka T., Liu S., Yu Y., Liu W., Anver M., Navid F., Helman L.J.et al. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat. Med. 8:2002;1276-1280.
32. Springer M.L., Rando T., Blau H.M. Gene delivery to muscle. Boyle A.L. Current Protocols in Human Genetics. 1997;John Wiley & Sons, New York. , pp. 13.4.1-13.4.19.
33. Takayama H., LaRochelle W.J., Sharp R., Otsuka T., Kriebel P., Anver M., Aaronson S.A., Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA. 94:1997;701-706.
34. Teitz T., Chang J.C., Kitamura M., Yen T.S., Kan Y.W. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene. Proc. Natl. Acad. Sci. USA. 90:1993;2910-2914.
35. Vogel K.S., Klesse L.J., Velasco-Miguel S., Meyers K., Rushing E.J., Parada L.F. Mouse tumor model for neurofibromatosis type 1. Science. 286:1999;2176-2179.
36. Wang Z.Q., Grigoriadis A.E., Mohle-Steinlein U., Wagner E.F. A novel target cell for c-fos-induced oncogenesis. development of chondrogenic tumours in embryonic stem cell chimeras EMBO J. 10:1991;2437-2450.
37. Wang Z.Q., Ovitt C., Grigoriadis A.E., Mohle-Steinlein U., Ruther U., Wagner E.F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:1992;741-745.